No connection

Search Results

Earnings Score 42 Bearish

BioMerieux Cuts 2026 Outlook Following Q1 Sales Slump

Apr 23, 2026 06:39 UTC
EYWN.MU, BIM.PA
Medium term

BioMerieux has lowered its full-year organic growth and income projections after reporting a decline in first-quarter sales. The company cited a soft market for instrument installations and a weaker respiratory season as key drivers.

  • Q1 consolidated sales reached 984 million euros
  • Reported sales declined 10.4% year-over-year
  • Organic sales growth guidance cut to 3%-5%
  • CEBIT growth outlook lowered to 0%-10%
  • Weak respiratory season and soft instrument market cited as causes

BioMerieux has revised its financial targets for 2026 following a contraction in first-quarter consolidated sales. The company reported sales of 984 million euros, marking a 10.4% decrease on a reported basis compared to the same period last year. On an organic basis, sales fell by 3.9%. Management attributed the downturn to a less active respiratory season compared to the exceptionally high epidemiological levels observed in the first quarter of the previous year. Additionally, the company noted a sluggish start to the year in instrument sales, reflecting a soft market for new installations. In response to these headwinds, BioMerieux has lowered its full-year 2026 guidance. The company now projects organic sales growth to be between 3% and 5%, a downward revision from its previous forecast of 5% to 7%. Profitability expectations were also adjusted. The company now expects organic growth in Contributive operating income before non-recurring items (CEBIT) to range between 0% and 10%, compared to the previous guidance of at least 10%.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Related Articles

Score 58

SK Hynix Posts Record Q1 Earnings as Market Expectations Peak

Apr 23, 09:42

Score 48 Bullish

STMicroelectronics Shares Climb on Strong Q1 Performance and Optimistic Q2 Guidance

Apr 23, 09:13

Score 55 Bearish

Goldman Sachs Forecasts Sluggish Q1 Earnings Growth for European Firms

Apr 23, 09:08

Score 62 Bullish

UnitedHealth Group Signals Turnaround with Strong Q1 Results and Raised Guidance

Apr 23, 09:04

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile